253 related articles for article (PubMed ID: 29601662)
21. Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men.
Powell IJ; Vigneau FD; Bock CH; Ruterbusch J; Heilbrun LK
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1505-11. PubMed ID: 24802741
[TBL] [Abstract][Full Text] [Related]
22. Should African-American men be tested for prostate carcinoma at an earlier age than white men?
Powell IJ; Banerjee M; Sakr W; Grignon D; Wood DP; Novallo M; Pontes E
Cancer; 1999 Jan; 85(2):472-7. PubMed ID: 10023717
[TBL] [Abstract][Full Text] [Related]
23. Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment.
Slezak JM; Van Den Eeden SK; Cannavale KL; Chien GW; Jacobsen SJ; Chao CR
Cancer Med; 2020 Nov; 9(22):8530-8539. PubMed ID: 32965775
[TBL] [Abstract][Full Text] [Related]
24. Survival of African American and non-Hispanic white men with prostate cancer in an equal-access health care system.
Riviere P; Luterstein E; Kumar A; Vitzthum LK; Deka R; Sarkar RR; Bryant AK; Bruggeman A; Einck JP; Murphy JD; Martínez ME; Rose BS
Cancer; 2020 Apr; 126(8):1683-1690. PubMed ID: 31984482
[TBL] [Abstract][Full Text] [Related]
25. Age-related racial disparities in prostate cancer patients: A systematic review.
He T; Mullins CD
Ethn Health; 2017 Apr; 22(2):184-195. PubMed ID: 27706949
[TBL] [Abstract][Full Text] [Related]
26. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
Bagley AF; Anscher MS; Choi S; Frank SJ; Hoffman KE; Kuban DA; McGuire SE; Nguyen QN; Chapin B; Aparicio A; Pezzi TA; Smith GL; Smith BD; Hess K; Tang C
JAMA Netw Open; 2020 Mar; 3(3):e201255. PubMed ID: 32191331
[TBL] [Abstract][Full Text] [Related]
27. Racial Disparities in Active Surveillance for Prostate Cancer.
Krishna S; Fan Y; Jarosek S; Adejoro O; Chamie K; Konety B
J Urol; 2017 Feb; 197(2):342-349. PubMed ID: 27596691
[TBL] [Abstract][Full Text] [Related]
28. Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Barrington WE; Schenk JM; Etzioni R; Arnold KB; Neuhouser ML; Thompson IM; Lucia MS; Kristal AR
JAMA Oncol; 2015 Jun; 1(3):342-9. PubMed ID: 26181184
[TBL] [Abstract][Full Text] [Related]
29. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
30. Racial disparity and survival outcomes between African-American and Caucasian American men with penile cancer.
Ritch CR; Soodana-Prakash N; Pavan N; Balise RR; Velasquez MC; Alameddine M; Adamu DY; Punnen S; Parekh DJ; Gonzalgo ML
BJU Int; 2018 May; 121(5):758-763. PubMed ID: 29281853
[TBL] [Abstract][Full Text] [Related]
31. Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
Cole AP; Herzog P; Iyer HS; Marchese M; Mahal BA; Lipsitz SR; Nyambose J; Gershman ST; Kennedy M; Merriam G; Rebbeck TR; Trinh QD
Cancer; 2021 Aug; 127(15):2714-2723. PubMed ID: 33999405
[TBL] [Abstract][Full Text] [Related]
32. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
[TBL] [Abstract][Full Text] [Related]
33. Does Any Racial Disparity Exist in Oncologic Outcomes After Primary Cryotherapy for Prostate Cancer? A Matched-pair Comparative Analysis of the Cryo On-Line Data Registry.
Aminsharifi A; Polascik TJ; Tsivian M; Schulman A; Tsivian E; Tay KJ; Elshafei A; Jones JS
Clin Genitourin Cancer; 2018 Oct; 16(5):e1073-e1076. PubMed ID: 30054221
[TBL] [Abstract][Full Text] [Related]
34. Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis.
Powell IJ; Dey J; Dudley A; Pontes JE; Cher ML; Sakr W; Grignon DJ; Wood DP
Urology; 2002 Jun; 59(6):907-12. PubMed ID: 12031379
[TBL] [Abstract][Full Text] [Related]
35. Disparities in Hispanic/Latino and non-Hispanic Black men with low-risk prostate cancer and eligible for active surveillance: a population-based study.
Katz JE; Chinea FM; Patel VN; Balise RR; Venkatramani V; Gonzalgo ML; Ritch C; Pollack A; Parekh DJ; Punnen S
Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):533-538. PubMed ID: 29988097
[TBL] [Abstract][Full Text] [Related]
36. Racial disparities in prostate cancer survival in a screened population: Reality versus artifact.
Kaur D; Ulloa-Pérez E; Gulati R; Etzioni R
Cancer; 2018 Apr; 124(8):1752-1759. PubMed ID: 29370459
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance.
Mahal AR; Mahal BA; Nguyen PL; Yu JB
Cancer; 2018 Feb; 124(4):752-759. PubMed ID: 29084350
[TBL] [Abstract][Full Text] [Related]
38. African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?
Sundi D; Ross AE; Humphreys EB; Han M; Partin AW; Carter HB; Schaeffer EM
J Clin Oncol; 2013 Aug; 31(24):2991-7. PubMed ID: 23775960
[TBL] [Abstract][Full Text] [Related]
39. Engaging African American Men as Citizen Scientists to Validate a Prostate Cancer Biomarker: Work-in-Progress.
Watson KS; Henderson V; Murray M; Murphy AB; Levi JB; McDowell T; Holloway-Beth A; Gogana P; Dixon MA; Moore L; Hall I; Kimbrough A; Molina Y; Winn RA
Prog Community Health Partnersh; 2019; 13(5):103-112. PubMed ID: 31378740
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer.
Krimphove MJ; Cole AP; Fletcher SA; Harmouch SS; Berg S; Lipsitz SR; Sun M; Nabi J; Nguyen PL; Hu JC; Kibel AS; Choueiri TK; Kluth LA; Trinh QD
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):125-136. PubMed ID: 30171227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
